Development and Validation of Human Psoriatic Skin Equivalents

2008/07/31 by Geuranne Tjabringa, Geuranne S. Tjabringa, Mieke Bergers +5 · 25 citations
Immunology and Microbiology · Medicine · #Biochemistry #Biology #Cytokine Signaling Pathways and Interactions #Dermatology #Dermatology and Skin Diseases #Equivalent #Internal medicine #Keratinocyte #Medicine #Psoriasis #Psoriasis: Treatment and Pathogenesis #Skin equivalent

paper · pdf · doi:10.2353/ajpath.2008.080173

openalex publication_date 2008/07/31 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Cited by

• Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. [europepmc]
• Artificial skin in perspective: concepts and applications. [europepmc]
• Establishment of a murine epidermal cell line suitable for in vitro and in vivo skin modelling. [europepmc]
• A DNA methylation fingerprint of 1628 human samples. [europepmc]
• Rho kinase inhibitor Y-27632 prolongs the life span of adult human keratinocytes, enhances skin equivalent development, and facilitates lentiviral transduction. [europepmc]
• Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis. [europepmc]
• Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. [europepmc]
• Tissue engineered human skin equivalents. [europepmc]
• Building a microphysiological skin model from induced pluripotent stem cells. [europepmc]
• Synthesis and activity of the salicylic acid ester of bakuchiol in psoriasis-surrogate keratinocytes and skin substitutes. [europepmc]
• Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models. [europepmc]
• Models in the Research Process of Psoriasis. [europepmc]
• Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis. [europepmc]
• Engineered Skin Tissue Equivalents for Product Evaluation and Therapeutic Applications. [europepmc]
• Infiltration of T Cells into a Three-Dimensional Psoriatic Skin Model Mimics Pathological Key Features. [europepmc]
• Recapitulating T cell infiltration in 3D psoriatic skin models for patient-specific drug testing. [europepmc]
• Perspective and Consensus Opinion: Good Practices for Using Organotypic Skin and Epidermal Equivalents in Experimental Dermatology Research. [europepmc]
• Utilizing Organoid and Air-Liquid Interface Models as a Screening Method in the Development of New Host Defense Peptides. [europepmc]
• Human skin models: From healthy to disease-mimetic systems; characteristics and applications. [europepmc]
• Development and characterization of a human Th17-driven ex vivo skin inflammation model. [europepmc]
• 3D micro-organisation printing of mammalian cells to generate biological tissues. [europepmc]
• In Vitro Disease Models for Understanding Psoriasis and Atopic Dermatitis. [europepmc]
• Induction of psoriasis- and atopic dermatitis-like phenotypes in 3D skin equivalents with a fibroblast-derived matrix. [europepmc]
• Monocytes and T cells incorporated in full skin equivalents to study innate or adaptive immune reactions after burn injury. [europepmc]
• Bilayered skin equivalent mimicking psoriasis as predictive tool for preclinical treatment studies. [europepmc]